Agenda
See our oligonucleotides and peptides tracks: click here below to expand the program
TRACK ON OLIGOS
14:00 – 14:25
Welcome – Networking and booth visiting
14:25 – 14:35
Welcome – Chairpersons
Brian Sproat
Chemconsilium GCV
Troels Koch
MINA Therapeutics
14:35 – 15:05
Nucleic Acids as Household Medicine: Living in the World of RNA Therapeutics
Muthiah Manoharan
Alnylam Pharmaceuticals
15:05 – 15:25
Oligonucleotide HBEL-based manufacturing
Eduardo Paredes
Nitto Denko Avecia
15:25 – 15:40
Networking Carousel + booth visiting
15:40 – 16:00
Oligonucleotides & Chromatography – what's new
Patrick Endres
Tosoh Bioscience
16:00 – 16:25
Spherical Nucleic Acids Facilitate Efficient Local Delivery Across Therapeutic Areas
Matthias Schroff
Exicure
16:25 – 16:45
Coffee Break and Networking Carousel + booth visiting
16:45 – 17:10
Extra-hepatic delivery of Centyrin-targeted siRNA conjugates
Steven Nadler
Aro Biotherapeutics
17:10 – 17:35
Ugimers: PNAs with a modified backbone to adjust pharmacological properties
Thomas Lindhorst
UGISense
17:35 – 18:00
Oligonucleotide Therapeutics for Rare Diseases: Meeting the Quality Challenges at Warp Speed
Susan Srivatsa
ElixinPharma
18:00 – 18:30
Final remarks – Networking and booth visiting
14:00 – 14:25
Welcome – Networking and booth visiting
14:25 -14:35
Welcome – Chairpersons
Brian Sproat
Chemconsilium GCV
Troels Koch
MINA Therapeutics
14:35 – 15:00
Liquid Phase Oligonucleotide Synthesis by Nanostar Sieving
Andrew Livingstone
Imperial College London
15:00 – 15:25
A novel, RNA-based anti-viral approach to limit BK virus propagation in immunocompromised patients
Eric van der Veer
Hybridize Therapeutics
15:25 – 15:45
The Future of Oncology Through the Lens of RNA
Zdravka Medarova
TransCode
15:45 – 16:10
Exploring new oligonucleotide backbone chemistries and their deployment to improve the properties of stereopure oligonucleotides
Pachamuthu Kandasamy
Wave Life Sciences
16:10 – 16:30
Coffee Break and Networking Carousel + booth visiting
16:30 – 16:55
Novel antisense therapy targeting microRNA-132 in heart failure: results of large animal studies and a first-in-human Phase 1b study
Janika Viereck
Cardior Pharmaceuticals
16:55 – 17:25
Capturing the Heart and Mind of Disease with RNA Targeting Technology
Richard S. Geary
Ionis Pharmaceuticals
17:25 – 18:05
Panel discussion – What do you see as the major technical challenges in the fast moving oligo therapeutics field?
18:05 – 18:30
Final remarks – Networking and booth visiting
TRACK ON PEPTIDES
14:00 – 14:25
Welcome – Networking and booth visiting
14:25 – 14:35
Welcome – Chairpersons
Fernando Albericio
University of Barcelona
Sara Pellegrino
University of Milan
14:35 – 15:05
Greening Solid Phase Peptide Synthesis: Challenges Ahead
Walter Cabri
Fresenius Kabi & University of Bologna
15:05 – 15:25
Development, optimization and scale up of therapeutic peptides: approaches to solid phase synthesis.
Andrew Kennedy
Gyros Protein Technologies
15:25 – 15:40
Networking Carousel + booth visiting
15:40 – 16:00
Innovation in chromatography processes: Cyclojet (isocratic binary separation) and GSSR (Gradient Central Cut Separation) as tools for complex tides separation
Lisa Audoy
Novasep
16:00 – 16:25
Fluorescent cyclic peptides for cell imaging
Marc Vendrell
University of Edinburgh
16:25 – 16:45
Coffee Break and Networking Carousel + booth visiting
16:45 – 17:10
Green Peptide Manufacturing: when a constraint becomes an opportunity
Olivier Ludemann-Hombourger
PolyPeptide Group
17:10 – 17:35
The Intelligent Repurposing™ of Glycopeptides to Target Urgent Threat Bacterial Pathogens
Jacob Rendell
SuperTrans Medical
17:35 – 18:00
Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives
Alessandra Tolomelli
University of Bologna
18:00 – 18:30
Final remarks – Networking and booth visiting
14:00 – 14:25
Welcome – Networking and booth visiting
14:25 – 14:35
Welcome – Chairpersons
Fernando Albericio
University of Barcelona
Sara Pellegrino
University of Milan
14:35 – 15:00
High-throughput discovery and parallel optimization of peptide therapeutics
Lauren Goodrich
Nimble Therapeutics
15:00 – 15:25
Orthogonal Purification of Peptides by IEX-RP Chromatography
Alessandra Basso
Purolite
15:25 – 15:45
Late Stage Functionalization of Histidine in Peptides
Anaïs F. M. Noisier
AstraZeneca
15:45 – 16:10
Optimizing the Pharmacokinetic Profile of Peptides by Novel “Fatty” Amino Acids
Thomas Bruckdorfer
Iris Biotech
16:10 – 16:30
Coffee Break and Networking Carousel + booth visiting
16:30 – 16:55
Peptide Easy Clean – a technology platform for novel peptide vaccines
Dominik Sarma
Belyntic
16:55 – 17:25
Refractometry to control the peptide synthesis
Beatriz G. de la Torre
University of KwaZulu-Natal
John Lopez
Novartis
17:25 – 18:05
Panel discussion – What do you see as the major technical challenges in the fast moving peptide therapeutics field?
18:05 – 18:30
Final remarks – Networking and booth visiting